Luoxin Pharmaceuticals Group Stock (002793.SZ): Zhongjue Fund and Kangqi Fund will become shareholders holding more than 5% of the shares.

Luoxin Pharmaceuticals Group Stock (002793.SZ) announcement: The company received notifications from shareholders holding more than 5% of the total shares, including Deyi Chengdu, Deyi Hengjia, Deyi Xinhua, Deyi Jiankang, and Desheng Jiankang, on November 19, 2024. Deyi Chengdu's manager, Deyi Investment Management (Beijing) Co., Ltd. (representing "Deyi Chengdu"), Deyi Hengjia, and Zhongjue Fund signed a "Share Transfer Agreement", with Deyi Chengdu planning to transfer 18.59 million unrestricted circulating shares through the agreement to Zhongjue Fund; Deyi Hengjia planning to transfer 35.79 million unrestricted circulating shares through the agreement to Zhongjue Fund. Deyi Jiankang, Desheng Jiankang, Deyi Chengdu's manager, Deyi Investment Management (Beijing) Co., Ltd. (representing "Deyi Jiankang", "Desheng Jiankang", "Deyi Chengdu" respectively), Deyi Xinhua, Chen Laiyang, and Kangqi Fund signed a "Share Transfer Agreement", with Deyi Jiankang planning to transfer 8.69 million unrestricted circulating shares to Kangqi Fund; Desheng Jiankang planning to transfer 1.9473 million unrestricted circulating shares to Kangqi Fund; Deyi Chengdu planning to transfer 16.7258 million unrestricted circulating shares to Kangqi Fund; Deyi Xinhua planning to transfer 24.9614 million unrestricted circulating shares to Kangqi Fund; Chen Laiyang planning to transfer 2.0518 million unrestricted circulating shares to Kangqi Fund. After the equity changes, Deyi Hengjia, Deyi Xinhua, Deyi Jiankang, Desheng Jiankang will no longer hold shares of the company. Deyi Chengdu holds 6.3769 million shares of the company, accounting for 0.59% of the total share capital, and the aforementioned shareholders will no longer be shareholders holding more than 5% in aggregate. Chen Laiyang holds 32.9986 million shares of the company, accounting for 3.03% of the total share capital; Zhongjue Fund holds 54.3794 million shares of the company, accounting for 5.00% of the total share capital, becoming a shareholder holding more than 5% of the company; Kangqi Fund holds 54.3794 million shares of the company, accounting for 5.00% of the total share capital, becoming a shareholder holding more than 5% of the company.